Santos Alexandra F, Bécares Natalia, Stephens Alick, Turcanu Victor, Lack Gideon
Division of Asthma, Allergy and Lung Biology, Department of Pediatric Allergy, St Thomas' Hospital, King's College London, 2nd Floor, Stairwell B, South Wing, Westminster Bridge Road, London, SE1 7EH UK ; MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK ; Immunoallergology Department, Coimbra University Hospital, Coimbra, Portugal ; Gulbenkian Programme for Advanced Medical Education, Lisbon, Portugal.
Division of Asthma, Allergy and Lung Biology, Department of Pediatric Allergy, St Thomas' Hospital, King's College London, 2nd Floor, Stairwell B, South Wing, Westminster Bridge Road, London, SE1 7EH UK ; MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.
Clin Transl Allergy. 2016 Apr 1;6:11. doi: 10.1186/s13601-016-0100-4. eCollection 2016.
Basophil activation test (BAT) reproduces IgE-mediated allergic reactions in vitro and has been used as a diagnostic test. Different markers can be used to identify basophils in whole blood and have implications for the outcome of the test. We aimed to assess changes in the expression of CD123 and HLA-DR following basophil activation and to select the best gating strategy for BAT using these markers.
BAT was performed in whole blood from 116 children. Peanut extract, anti-IgE, anti-FcεRI or formyl-methionyl-leucyl-phenylalanin (fMLP) was used for stimulation. Surface expression of CD123, HLA-DR, CD63 and CD203c was evaluated by flow cytometry.
In some cases, gating on CD123+/HLA-DR- led to the loss-to-analysis of basophils in conditions where basophils were activated. Adding CD203c as an identification marker restored the cell number. Basophils remained HLA-DR-negative with activation. CD123 expression decreased following stimulation with fMLP (n = 116, p < 0.001), anti-IgE (n = 104, p < 0.001) and peanut (n = 42, p < 0.001). The decrease in the mean fluorescence intensity of CD123 correlated with the up-regulation of basophil activation markers, CD63 (rs = -0.31, p < 0.001) and CD203c (rs = -0.35, p < 0.001). BAT to peanut gating basophils on CD203c+/CD123+/HLA-DR- reduced the false-negatives (1 vs. 5 %) and showed a higher diagnostic accuracy compared to using CD123+/HLA-DR- (97 vs. 91 %). CD203c+ appeared as an alternative gating strategy allowing two-colour BAT.
Basophils of a subset of patients down-regulate CD123 with activation. The use of CD203c before gating on CD123+/HLA-DR- cells or in isolation ensures the identification of the entire basophil population and accurate assessment of basophil activation, with important diagnostic implications.
嗜碱性粒细胞活化试验(BAT)可在体外重现IgE介导的过敏反应,已被用作一种诊断测试。可使用不同的标志物来识别全血中的嗜碱性粒细胞,这对测试结果有影响。我们旨在评估嗜碱性粒细胞活化后CD123和HLA-DR表达的变化,并使用这些标志物选择BAT的最佳设门策略。
对116名儿童的全血进行BAT。使用花生提取物、抗IgE、抗FcεRI或甲酰甲硫氨酰亮氨酰苯丙氨酸(fMLP)进行刺激。通过流式细胞术评估CD123、HLA-DR、CD63和CD203c的表面表达。
在某些情况下,在嗜碱性粒细胞被激活的条件下,基于CD123+/HLA-DR-设门将导致嗜碱性粒细胞分析丢失。添加CD203c作为识别标志物可恢复细胞数量。嗜碱性粒细胞在激活后仍为HLA-DR阴性。用fMLP(n = 116,p < 0.001)、抗IgE(n = 104,p < 0.001)和花生(n = 42,p < 0.001)刺激后,CD123表达降低。CD123平均荧光强度的降低与嗜碱性粒细胞活化标志物CD63(rs = -0.31,p < 0.001)和CD203c(rs = -0.35,p < 0.001)的上调相关。基于CD203c+/CD123+/HLA-DR-对花生进行BAT设门嗜碱性粒细胞可减少假阴性(1%对5%),与使用CD123+/HLA-DR-相比,显示出更高的诊断准确性(97%对91%)。CD203c+似乎是一种允许双色BAT的替代设门策略。
一部分患者的嗜碱性粒细胞在激活后下调CD123。在基于CD123+/HLA-DR-细胞设门之前或单独使用CD203c可确保识别整个嗜碱性粒细胞群体并准确评估嗜碱性粒细胞活化,具有重要的诊断意义。